F. David King
Keine laufenden Positionen mehr
Profil
F.
David King worked as Vice President-Business Development at Avid Bioservices, Inc., Principal at DepoTech Corp., Maxim Pharmaceuticals, Inc., and Glaxo, Inc. He also worked as Vice President-Corporate Development at Medinox, Inc. King received his undergraduate degree from Goshen College, Inc.
Ehemalige bekannte Positionen von F. David King
| Unternehmen | Position | Ende |
|---|---|---|
| Glaxo, Inc. | Corporate Officer/Principal | - |
DepoTech Corp.
 DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Medinox, Inc.
 Medinox, Inc. Pharmaceuticals: MajorHealth Technology Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | - |
| Maxim Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| AVID BIOSERVICES, INC. | Corporate Officer/Principal | - |
Ausbildung von F. David King
| Goshen College, Inc. | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AVID BIOSERVICES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Medinox, Inc.
Medinox, Inc. Pharmaceuticals: MajorHealth Technology Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA. | Health Technology |
| Maxim Pharmaceuticals, Inc. | Health Technology |
DepoTech Corp.
DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | Health Technology |
| Glaxo, Inc. |
